New appointment at Ecron Acunova
This article was originally published in Scrip
Executive Summary
The CRO Ecron Acunova has appointed Dr Antal Hajos managing director and CEO Europe. He will be based at the company's European headquarters in Hamburg, Germany. Dr Hajos has more than 15 years' experience in the pharmaceutical and CRO industries, having previously served as director of global clinical operations at Altana Pharma.
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.